Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pernix Theraptcs (PTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,285
  • Shares Outstanding, K 11,640
  • Annual Sales, $ 140,860 K
  • Annual Income, $ -169,590 K
  • 36-Month Beta 1.68
  • Price/Sales 0.21
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 unch
on 12/14/17
3.11 -26.05%
on 11/16/17
-0.78 (-25.32%)
since 11/14/17
3-Month
2.30 unch
on 12/14/17
3.35 -31.34%
on 09/25/17
-0.47 (-16.97%)
since 09/14/17
52-Week
1.83 +25.68%
on 12/28/16
7.15 -67.83%
on 05/10/17
-0.38 (-14.18%)
since 12/14/16

Most Recent Stories

More News
Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced the election of two new directors to its Board, John R. Leone and Douglas...

WINT : 0.2400 (+4.35%)
PTX : 2.30 (-5.35%)
Pernix Therapeutics Reports Third Quarter 2017 Financial Results

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, announced today financial results for the third quarter ended September 30, 2017.

PTX : 2.30 (-5.35%)
Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30...

PTX : 2.30 (-5.35%)
Pernix Therapeutics Announces Sale of Non-Core Product

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax(R) (ceftibuten capsules and ceftibuten...

PTX : 2.30 (-5.35%)
Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, announced today that the Company will report financial results for the third quarter ended...

PTX : 2.30 (-5.35%)
Pernix Therapeutics Announces Planned Departure of Chief Financial Officer

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced that Graham Miao, Ph.D., President and Chief Financial Officer (CFO), will...

PTX : 2.30 (-5.35%)
BUYINS.NET: PTX SqueezeTrigger Price is $2.83. There is $5,107,955 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) in real time and just received an alert that PTX is crossing above its primary SqueezeTrigger Price, the price that...

PTX : 2.30 (-5.35%)
Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2017.

PTX : 2.30 (-5.35%)
Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q2 Earnings Call to be held July 27, 2017 at 4:30 PM Eastern...

PTX : 2.30 (-5.35%)
Platinex Joins Forces With FMI Capital Advisory Inc. to Pursue Transactions in the Cannabis Space

TORONTO, ONTARIO--(Marketwired - July 25, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") has engaged FMI Capital Advisory Inc. ("FMI") as financial advisor to assist...

PTX : 2.30 (-5.35%)
PTX.CN : 0.130 (unch)
PANXF : 0.0690 (-13.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex,...

See More

Key Turning Points

2nd Resistance Point 2.50
1st Resistance Point 2.40
Last Price 2.30
1st Support Level 2.25
2nd Support Level 2.20

See More

52-Week High 7.15
Fibonacci 61.8% 5.12
Fibonacci 50% 4.49
Fibonacci 38.2% 3.86
Last Price 2.30
52-Week Low 1.83

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.